Obese parturients require 1.597 times higher norepinephrine dose to prevent hypotension during cesarean deliveryTrial shows obese patients need more medication for stable blood pressure

African journal of reproductive health Published August 10, 2026 Study authors: Chen Xiaoping, Gao Zhenyu, Jiao Cuicui, Wang Jialin, Sun Lihong, Qian Xiaowei, Liu Shuqun PubMed ↗ DOI ↗ Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Note that obese parturients require a 1.597 higher dose of norepinephrine to prevent hypotension during cesarean delivery.

This randomized, double-blind, dose-response study evaluated the efficacy of norepinephrine infusions in 200 parturients undergoing elective cesarean delivery under combined spinal-epidural anesthesia with 16 mg ropivacaine. The population was stratified into normal weight (BMI 18.5-24.9 kg/m^2) and obese (BMI \u226530 kg/m^2) groups.

The primary outcome was the success of preventing hypotension, defined as SBP <90 mmHg or a >20% decrease from baseline. The study identified distinct dose-response thresholds for both groups. For normal weight patients, the ED50 was 0.022 µg\u00b7kg\u00b1min\u00b9 (95% CI 0.015-0.029) and the ED95 was 0.051 µg\u00b7kg\u00b1min\u00b9 (95% CI 0.041-0.061).

In contrast, the obese group required higher doses to achieve similar outcomes: the ED50 was 0.036 µg\u00b7kg\u00b1min\u00b9 (95% CI 0.029-0.043) and the ED95 was 0.080 µg\u00b7kg\u00b1min\u00b9 (95% CI 0.058-0.102). The relative potency ratio between the obese and normal weight groups was 1.597 (95% CI 1.007-2.187; P=0.013).

Maternal adverse effects were reported as comparable between the two groups. While the study suggests that obese parturients require higher weight-adjusted norepinephrine infusion rates to prevent hypotension, clinical application should consider these specific dose thresholds when managing spinal anesthesia-induced hemodynamic changes.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in maternal management during cesarean delivery by quantifying the specific dosage requirements for different BMI groups. While previous coverage noted that arterial hypotension is a late sign of decompensated shock linked to increased mortality and adverse neurologic outcomes in critically ill children, this study focuses on preventing such hypotension in parturients using norepinephrine. It provides specific potency ratios (1.597) to guide pharmacological intervention based on patient weight status.

When a woman undergoes a cesarean delivery, maintaining stable blood pressure is vital. However, certain types of anesthesia can cause blood pressure to drop suddenly. This study looked at how much of a medication called norepinephrine—which helps keep blood pressure up—is needed for different patients during these surgeries.

The researchers studied 200 women undergoing elective C-sections. They compared two groups: those with a normal weight and those who were obese. The results showed that the amount of medicine needed to prevent low blood pressure was significantly higher in the group of patients with a higher BMI. Specifically, the potency ratio showed that these patients required more medication to achieve the same stability.

While the study confirms that dosage needs vary based on body weight, it also noted that maternal side effects were similar between both groups. This finding helps doctors tailor their approach to ensure every patient stays stable during surgery. Because every medical situation is unique, patients should discuss these specific dosing details with their surgical team.

What this means for you:

Obese patients require higher doses of norepinephrine to prevent low blood pressure during C-section surgeries.

Common questions

How does this study help people having a C-section?

The study helps doctors determine the correct amount of norepinephrine, a medication used to keep blood pressure steady. It found that patients with a higher BMI need a higher dose compared to those with a normal weight to prevent their blood pressure from dropping during surgery.

Was the medication safe for both groups?

The study reported that maternal adverse effects were comparable between the normal weight and obese groups. This means that while the amount of medicine needed differed based on body weight, the general safety profile of the treatment remained similar for both types of patients.

Study Details

Study typeRct

EvidenceLevel 2

PublishedAug 2026

PMID42544724

View Original Abstract ↓

Obese parturients are at increased risk of spinal anesthesia-induced hypotension during cesarean delivery, but optimal prophylactic norepinephrine dosing remains unclear. In this randomized, double-blind, dose-response study, 200 parturients undergoing elective cesarean delivery were stratified into obese (BMI ≥30 kg/m²) and normal weight (BMI 18.5-24.9 kg/m²) groups. Within each group, patients received norepinephrine infusion at 0.02-0.06 µg·kg⁻¹·min⁻¹. Standardized combined spinal-epidural anesthesia with 16 mg hyperbaric ropivacaine was used, and infusion was started immediately after spinal injection. Hypotension was defined as SBP <90 mmHg or >20% decrease from baseline, and success as absence of hypotension. Probit regression was used to estimate ED50 and ED95. ED50 and ED95 were 0.022 (95% CI 0.015-0.029) and 0.051 (0.041-0.061) µg·kg⁻¹·min⁻¹ in normal weight, compared with 0.036 (0.029-0.043) and 0.080 (0.058-0.102) µg·kg⁻¹·min⁻¹ in obese parturients. The relative potency ratio was 1.597 (95% CI 1.007-2.187; P=0.013). Neonatal outcomes and maternal adverse effects were comparable. Obese parturients require higher weight-adjusted norepinephrine infusion rates to prevent spinal anesthesia-induced hypotension during cesarean delivery.

Obese parturients require 1.597 times higher norepinephrine dose to prevent hypotension during cesarean deliveryTrial shows obese patients need more medication for stable blood pressure

How this fits prior evidence

Common questions

Study Details

Efficacy and Safety Profile of Subcutaneous Semaglutide for Weight Management in Adults

Semaglutide helps people with obesity lose significant body weight

Clinical research that matters. Delivered to your inbox.

Obese parturients require 1.597 times higher norepinephrine dose to prevent hypotension during cesarean deliveryTrial shows obese patients need more medication for stable blood pressure

How this fits prior evidence

Common questions

More on ropivacaine

Study Details

Efficacy and Safety Profile of Subcutaneous Semaglutide for Weight Management in Adults

Semaglutide helps people with obesity lose significant body weight

Clinical research that matters. Delivered to your inbox.

Related in Diabetes & Endocrinology

From Other Specialties